Through
4/30
Two Penn Professors Named National Academy of Inventors Fellows
Professors James Eberwine, of the University of Pennsylvania’s Perelman School of Medicine and Shu Yang, of Penn’s School of Engineering and Applied Science, have been
Penn Researchers Tame the Inflammatory Response in Kidney Dialysis
Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent.
Penn Study Points to New Therapeutic Strategy in Chronic Kidney Disease
Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease’s progress towards kidney failure.
Penn Researchers Unwind the Mysteries of the Cellular Clock
Human existence is basically circadian. Most of us wake in the morning, sleep in the evening, and eat in between. Body temperature, metabolism, and hormone levels all fluctuate throughout the day, and it is increasingly clear that disruption of those cycles can lead to metabolic disease.
Classification of Gene Mutations in a Children's Cancer May Point to Improved Treatments
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
See-Through, One-Atom-Thick, Carbon Electrodes are a Powerful Tool for Studying Epilepsy, Other Brain Disorders, Penn Study Finds
Researchers from the Perelman School of Medicine and School of Engineering at the University of Pennsylvania and The Children's Hospital of Philadelphia have used graphene -- a two-dimensional form of carbon only one atom thick -- to fabricate a
Penn Medicine: New Gene Therapy for "Bubble Boy" Disease Appears to be Safe, Effective
A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a life-threatening condition also known as “bubble boy” disease, appears to be both effective and safe, according to an international clinical trial with sites in Boston, Cincinnati, Los Angeles, London, and Paris.
Penn Study Demonstrates Efficacy of Potential Therapy for Autoimmune Disorder of Muscle Weakness
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
Penn Researchers Explain How Ends of Chromosomes Are Maintained for Cancer Cell Immortality
Maintaining the ends of chromosomes, called telomeres, is a requisite feature of cells that are able to continuously divide and also a hallmark of human cancer.
Penn Researchers Describe New Cancer Drug Target Involving Lipid Chemical Messengers
More than half of human cancers have abnormally upregulated chemical signals related to lipid metabolism, yet how these signals are controlled during tumor formation is not fully understood.